Name (Synonyms) | Correlation | |
---|---|---|
drug1959 | Q16 testing Wiki | 1.00 |
drug1664 | Observation of patients with known, suspected, or at risk for COVID-19 infection Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
The primary objective of the study is to determine whether, at 21 days, care homes that implemented near-patient daily testing have a lower rate of confirmed CoV-2 infections than care homes following the DHSC standard of care testing of symptomatic residents.
Description: The cumulative number of confirmed cases of CoV-2 infection after 21 days, measured by PCR detection of CoV-2, within the care home residents, staff and visitors
Measure: CoV-2 Infection after 21 days Time: 21 daysDescription: The cumulative number of confirmed cases of CoV-2 infection after 14 days, measured by PCR detection of CoV-2, within the care home residents, staff and visitors.
Measure: CoV-2 Infection after 14 days Time: 14 daysDescription: The cumulative number of suspected or confirmed cases of CoV-2 infection after 14 days, within the care home residents, staff and visitors.
Measure: Cases of suspected or confirmed CoV-2 infection Time: 14 daysDescription: The cumulative number of confirmed COVID-19-related hospitalisations and deaths of care home residents, staff and visitors after 21 and 40 days.
Measure: Hospitalisation and death Time: 21 days and 40 days